BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022

Avance Clinical is taking meetings with biotechs to discuss the benefits of conducting trials in Australia, including no IND requirement and an attractive ...

January 18, 2022 | News

How to Choose the Right At-Home COVID Test

Insight follows announcement that the Biden administration will purchase 500 million rapid COVID-19 tests and distribute free of cost to Americans With th...

December 22, 2021 | News

TCM provides new alternatives for the fight against COVID-19

Dr. Chen Zhen, President of the Central and Eastern European Federation of Chinese Medicine Societies, said that the Hungarian Qihuang TCM Center prov...

December 22, 2021 | News

Microba Life Sciences Becomes First Australian Microbiome Company Granted ISO15189 Accreditation by NATA

he hypothesis-free testing method, MetaPanelTM, can identify multiple pathogens simultaneously from a single sample and was developed in partnership with A...

December 20, 2021 | News

First Patient Dosed in Australia in ATG-101 First-in-Human Trial

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developin...

December 20, 2021 | News

Servatus to advance autoimmune therapies in Australia

Servatus has raised $7.5 million in an oversubscribed capital raise, with strong support from sophisticated shareholders Funds raised will und...

December 09, 2021 | News

Effort to reduce burden of disease in Australia shines spotlight on natural medicine to support liver health

The prevalence of liver health issues is emerging as a serious cost and health burden for Australia with the spotlight on evidence-based natural ...

December 07, 2021 | Analysis

Starpharma signs distribution agreement for VIRALEZE™ antiviral nasal spray in Vietnam

Australian biotech company Starpharma has signed a 5-year supply and distribution arrangement for its VIRALEZE™ antiviral nasal spray in&nb...

December 06, 2021 | News

Clarity and Cardinal Health to address the growing needs in oncology

Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growin...

December 03, 2021 | News

World-first lung cancer screening facility increases chance of cure

The truck will be fitted with the latest technology, integrating imaging, breath and blood biomarker screening, as part of a $2 million Australian Can...

December 01, 2021 | Influencers

EQT Infrastructure to acquire Icon Group, Australia's largest integrated cancer care provider

Icon Group is Australia's largest vertically integrated cancer care provider, offering radiation oncology, medical oncology, compounding an...

November 19, 2021 | News

$5M Boost to Innovation in Australia with New Illumina Genomics Lab

Illumina, Inc. (NASDAQ: ILMN), the global leader in genomics, today announced the opening of a new, fully equipped laboratory to help Australian researcher...

November 15, 2021 | News

Research into gut microbiome-autism link reveals new perspective in collaborative Austism CRC study

In the largest study in the field to date, researchers analysed stool samples using Microba's metagenomic analysis, alongside other clinical and biological...

November 12, 2021 | News

Life sciences’ highest achievers awarded with prestigious Industry Excellence Awards

Australian Company of the Year: SpeeDx Australian Emerging Company of the Year: oNKo-innate • Industry Leadership Award: David B...

November 01, 2021 | News

Stay Connected